RecruitingNot Applicable

Cellular Markers in Treated or Untreated Non-tuberculous Mycobacterial Respiratory Infection in Patients With Cystic Fibrosis

France76 participantsStarted 2024-09-17

Plain-language summary

This study evaluates a diagnostic serological test for Non-Tuberculous Mycobacteria (NTM) infection in cystic fibrosis patients by measuring T cell response. It aims to highlight a dynamic response associated to the pathogen's presence. This multicenter case-control study involves two populations, providing a better understanding of the circulating T-IFNγ-MNT response in these patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient ≥18 years * Patient previously included in the CIMeNT study * Patient with a confirmed diagnosis of cystic fibrosis regardless of CFTR genotype * Patient affiliated to the social security system * Patient registered in the French Cystic Fibrosis Registry * Adult patient capable of spontaneous expectoration or after induction Exclusion Criteria: * Lung transplant patients * Person placed under judicial protection * Pregnant and breastfeeding women

What they're measuring

Determination of interferon-gamma release assay

Timeframe: day 1 (V1)

Trial details

NCT IDNCT06602869

SponsorUniversity Hospital, Montpellier

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-08-01

Contact for this trial

Raphael CHIRON, MD

0467336115 r-chiron@chu-montpellier.fr

View on ClinicalTrials.gov More Non-Tuberculous Mycobacterial Pneumonia trials